It remains unknown whether the C-C motif chemokine receptor type 5 (CCR5) coreceptor is still the predominant coreceptor used by Human Immunodeficiency Virus-1 (HIV-1) in Botswana, where the HIV-1 subtype C predominates. We sought to determine HIV-1C tropism in Botswana using genotypic tools, taking into account the effect of antiretroviral treatment (ART) and virologic suppression. HIV-1 gp120 V3 loop sequences from 5602 participants were analyzed for viral tropism using three coreceptor use predicting algorithms/tools: Geno2pheno, HIV-1C Web Position-Specific Score Matrices (WebPSSM) and the 11/25 charge rule. We then compared the demographic and clinical characteristics of people living with HIV (PLWH) harboring R5- versus X4-tropic viru...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
HIV infects target cells by binding of its envelope gp120 protein to CD4 and a coreceptor on the cel...
HIV infects target cells by binding of its envelope gp120 protein to CD4 and a coreceptor on the cel...
Genotypic tropism testing (GTT) has been developed largely on HIV-1 subtype B. Although a few report...
Background. CXCR4-using virus is associated with higher viral load and accelerated human immunodefic...
OBJECTIVE: The discovery of two main coreceptors for human immunodeficiency virus (HIV), C-C chemo...
Background: The use of CCR5 antagonists involves determination of HIV-1 tropism prior to initiation ...
The use of CCR5 antagonists involves determination of HIV-1 tropism prior to initiation of treatment...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
In human immunodeficiency virus type 1 (HIV-1) subtype B, CXCR4 coreceptor use ranges from 20 % in e...
Background. Human immunodeficiency virus type 1 (HIV-1) coreceptor tropism, the ability of the virus...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
HIV infects target cells by binding of its envelope gp120 protein to CD4 and a coreceptor on the cel...
HIV infects target cells by binding of its envelope gp120 protein to CD4 and a coreceptor on the cel...
Genotypic tropism testing (GTT) has been developed largely on HIV-1 subtype B. Although a few report...
Background. CXCR4-using virus is associated with higher viral load and accelerated human immunodefic...
OBJECTIVE: The discovery of two main coreceptors for human immunodeficiency virus (HIV), C-C chemo...
Background: The use of CCR5 antagonists involves determination of HIV-1 tropism prior to initiation ...
The use of CCR5 antagonists involves determination of HIV-1 tropism prior to initiation of treatment...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
In human immunodeficiency virus type 1 (HIV-1) subtype B, CXCR4 coreceptor use ranges from 20 % in e...
Background. Human immunodeficiency virus type 1 (HIV-1) coreceptor tropism, the ability of the virus...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
Objectives: Although founder viruses in primary HIV-1 infections (PHIs) typically use the CCR5 corec...
HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) virus...
HIV infects target cells by binding of its envelope gp120 protein to CD4 and a coreceptor on the cel...
HIV infects target cells by binding of its envelope gp120 protein to CD4 and a coreceptor on the cel...